In vitro synergy testing of anidulafungin with fluconazole, tioconazole, 5-flucytosine and amphotericin B against some Candida spp.
Authors: Rosato A,Piarulli M,Schiavone BI,Montagna MT,Caggiano G,Muraglia M,Carone A,Franchini C,Corbo F,
Address: Department of Pharmaceutical Chemistry, Section of Microbiology, Faculty of Pharmacy, University of Bari, Aldo Moro, Bari, Italy. firstname.lastname@example.org
Journal: Med Chem.
Publication: 2012 Jul;8(4):690-8.
In this paper the authors investigated a synergistic antimycotic effect between four antifungal drugs amphotericin B, fluconazole, tioconazole, and flucytosine individually combined with anidulafungin compound. This latter is considered a drug of choice in the treatment of fungal infections; it has good activity both in vitro and in vivo against yeasts and moulds, as Candida and Aspergillus. The goal of this study was to evaluate the in vitro interaction of Anidulafungin in the synergic combinations with previous reported drugs against 12 Candida strains according to CLSI M27-A3 protocol. A synergistic interaction was observed against the most antifungal strains; in particular an increasing of the antimycotic efficacy was obtained from the association between Anidulafungin and Amphotericin B or Fluconazole (Mixture 4:6). In contrast the association Tioconazole/Anidulafungin was less effective on fungal species growth. The antimycotics MIC reduction values were more evident against some strains as C. glabrata, C. krusei, C. tropicalis and C. parapsilosis.
The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.